JUNSHI BIO

01877

Current ValuationThe current P/E ratio is -35.60, below the reasonable range, cheaper than 92.73% of the time in the past 3 years, and the industry ranks 69/78, the industry Median -4.96.

-35.6xP/E
Stock priceHK$15.93Earnings per shareHK$-0.45

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
0159318477636

The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
P/E ratio
Name/Symbol
09926HKAKESO
-74.25x75.50%HK$82.68B
09688HKZAI LAB
-14.61x435.53%HK$22.73B
01877HKJUNSHI BIO
-35.60x94.97%HK$16.36B
07666HKMETIS TECHBIO-P
-32.77x96.67%HK$13.34B
02627HKAB&B BIO-TECH-B
-46.87x--HK$11.54B
06855HKASCENTAGE
-6.71x18.76%HK$11.34B
09606HKDUALITYBIO-B
-6.11x85.35%HK$10.12B
01952HKEVEREST MED
-158.81x326.79%HK$9.86B
02595HKGENFLEET-B
-5.98x66.07%HK$9.07B
02616HKCSTONE PHARMA-B
-18.65x1.09%HK$9.00B
02493HKMABWELL-B
-6.76x--HK$8.27B
09887HKLEADS BIOLABS-B
-24.69x3.57%HK$7.59B
06938HKRIBOLIFE-B
-38.40x29.56%HK$7.50B
02171HKCARSGEN-B
-65.80x52.33%HK$6.76B
09966HKALPHAMAB-B
-31.72x--HK$6.43B
02335HKMICOT PHARMA-B
-12.91x37.52%HK$5.42B
01672HKASCLETIS-B
-7.56x78.53%HK$5.15B
00775HKCKLIFE SCIENCES
-78.73x--HK$5.09B
02256HKABBISKO-B
-9.36x797.83%HK$5.03B
01779HKLONGBIO-B
-16.97x--HK$4.22B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.